ClinicalTrials.gg
RecruitingNCT07715591SLinUpdated Oct 2, 2026

Randomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery

An interventional study of Music and Guided Imagery and Control in Cataract and Cataract (Post-operative Cataract Surgery Follow-up), sponsored by University of California, Los Angeles. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 2, 2026Primary completion movedStudy completion movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Sex
All
01

Study summary

This randomized controlled trial evaluates whether a standardized perioperative neuroplastic intervention: the STEIN Protocol (Strategies and Techniques for Enhancing Integration and Neuroplasticity), consisting of pain neuroscience education, guided imagery, and paced breathing, reduces intraoperative analgesic and anxiolytic requirements.

Secondary outcomes include patient-reported pain, anxiety, satisfaction, and postoperative recovery following cataract surgery.

Reduced intraoperative sedative and analgesic requirements may reflect improved patient comfort and autonomic regulation while minimizing medication-related adverse effects.

Read the detailed description

The STEIN Protocol is a randomized behavioral intervention designed to evaluate whether standardized, non-pharmacologic interventions can help patients have a more comfortable and safe surgical experience.

Cataract surgery provides a highly standardized operative model with minimal procedural variability, making it well suited for evaluating perioperative behavioral interventions while minimizing confounding from surgical complexity.

The intervention is based on contemporary models of pain neuroscience, which propose that cognitive appraisal, expectancy, autonomic regulation, and attentional processes influence pain perception independent of tissue injury.

Participants in the study will receive standard cataract surgery, with some patients also taking part in the STEIN Protocol. This includes watching a short educational video before surgery, following slow, guided breathing during the procedure, and practicing brief breathing exercises at home for one week after surgery. The intervention is designed to reduce sympathetic arousal and promote parasympathetic regulation through standardized paced breathing and guided cognitive attention.

The intervention is intended to modify cognitive appraisal, attentional focus, and autonomic regulation, thereby influencing pain perception throughout the perioperative period.

The study will compare pain levels, medication use, recovery, and patient satisfaction between groups to determine whether this standardized, scalable approach can improve the surgical experience and potentially benefit patients undergoing many types of surgery in the future.

We hypothesize that participants receiving the STEIN Protocol will require less intraoperative anxiolytic and analgesic medication while reporting lower pain, lower anxiety, and greater satisfaction than participants receiving standard care.

Surgical technique, anesthetic management, questionnaire administration, and postoperative follow-up will be standardized across study groups.

Adherence to each component of the intervention will be documented to assess intervention fidelity.

02

Conditions studied

  • Cataract
  • Cataract (Post-operative Cataract Surgery Follow-up)

Keywords

  • Cataract Surgery
  • Pain Neuroscience Education
  • Guided Imagery
  • Guided Breathing
  • Perioperative Care
  • Anxiety
  • Patient Satisfaction
  • Mind-Body Medicine
  • Meditation
  • Breathwrok
  • Pain
03

In context

Cataract

1,629 studies on the registry are indexed under Cataract; 235 are open to participants now.

This study's planned enrollment of 300 is above the median of 79 across 1,092 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,170 studies on the registry; 195 are open to participants now.

Of its 95 completed or terminated interventional studies of FDA-regulated products, 70 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults undergoing elective cataract surgery under topical anesthesia who are able to provide and complete study procedures.

Exclusion criteria

Exclusion Criteria:

Inability to provide Inability to comply with study procedures Complex or combined cataract surgery General anesthesia Medical, neurologic, psychiatric, or respiratory conditions interfering with study participation Requirement for modified anesthetic protocols Inability to complete postoperative breathing exercises or follow-up assessments

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
300 participants (estimated)

Study arms

  • Placebo comparator
    Control

    Device: Control

  • Experimental
    Music + Guided Imagery

    Music and Guided Imagery

    Device: Music and Guided Imagery

  • Experimental
    Music Only

    Music Only

    Device: Music Only

Interventions

  • DeviceMusic and Guided Imagery

    Participants wear open-ear headphones during cataract surgery. Every 3 minutes, a voice will ask if the patient would like more relaxing medication or pain medication. Participants receive the STEIN Protocol, consisting of preoperative pain neuroscience education, intraoperative audio-guided paced breathing and guided imagery, and postoperative home breathing exercises. The open-ear headphones allow participants to hear and communicate with the surgeon and operating room staff at all times. The audio may be stopped at any time if requested or clinically indicated. No additional medications or medical procedures are administered as part of the intervention, and all other aspects of surgical and anesthetic care remain unchanged.

  • DeviceControl

    Participants wear open-ear headphones during cataract surgery. Every 3 minutes, a voice will ask if the patient would like more relaxing medication or pain medication.

  • DeviceMusic Only

    Participants wear open-ear headphones during cataract surgery. Every 3 minutes, a voice will ask if the patient would like more relaxing medication or pain medication. Participants receive the music protocol, consisting of preoperative pain neuroscience education, intraoperative music, and postoperative home breathing exercises. The open-ear headphones allow participants to hear and communicate with the surgeon and operating room staff at all times. The audio may be stopped at any time if requested or clinically indicated. No additional medications or medical procedures are administered as part of the intervention, and all other aspects of surgical and anesthetic care remain unchanged.

06

What researchers measure

Primary outcomes

  1. Total cumulative intraoperative dose of anxiolytic and analgesic medications (midazolam [mg], fentanyl [mcg], and additional rescue medications, recorded separately).

    Time frame: From initiation of surgery until completion of surgery.

Secondary outcomes

  1. Iowa Satisfaction with Anesthesia Scale (ISAS)

    Validated clinical survey instrument

    Time frame: Within 30 minutes of surgery completion

  2. Numeric Rating Scale pain score (0-10)

    Validated clinical survey instrument

    Time frame: Within 30 minutes of surgery completion

  3. Amsterdam Preoperative Anxiety and Information Scale (APAIS)

    Validated clinical survey instrument

    Time frame: 30 minutes prior to surgery

  4. Additional questions

    Investigator-developed exploratory questionnaire evaluating perceived comfort, communication, perceived control, and overall surgical experience.

    Time frame: Within 30 minutes after surgery completion

07

Study locations

1 of 1 sites recruiting
  • Stein Eye Institute - University of California Los Angeles
    Los Angeles, California 90025, United States
    Recruiting
    • Shawn R Lin, MD, MS, MBA · Contactslin@jsei.ucla.edu · 310-206-7955
    • Shawn R Lin, MD, MS, MBA · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data, study protocol, statistical analysis plan, informed consent form, and supporting study documents will be made available upon reasonable request following publication, subject to institutional review and IRB requirements.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: After publication for 1 year

Access criteria: The researcher can email the study PI to obtain the IPD.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Primary completion
Sep 1, 2026→Dec 31, 2026
Oct 2, 2026
Study completion
Sep 1, 2026→Dec 31, 2026
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Primary completion Sep 1, 2026→Dec 31, 2026
    Study completion Sep 1, 2026→Dec 31, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07715591
Responsible party
Shawn R. Lin, MD, MBA (Associate Clinical Professor of Ophthalmology, University of California, Los Angeles) — Principal investigator
First posted
Jul 20, 2026
Start date
Jun 10, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 2, 2026

Study contacts

Shawn R Lin, MD, MS, MBA
Contact
slin@jsei.ucla.edu
310-206-7955

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion